BASF India Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 17 Jul 2026 | Chemicals & Petrochemicals | Market Cap: ₹17.5K Cr
Agricultural Solutions business is expected to grow driven by volume recovery in upcoming rabbi season, new product launches, and focus on specialty crops like rice and rubber-based applications (2 and 3 wheelers). Earnings/profits have been impacted recently by higher input costs and unfavorable product mix, leading to a 27% reduction in PBT before exceptional items for six months compared to last year.
From BASF India Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹3,903
Market Cap
₹17.5K Cr
P/E Ratio
28.2
How does BASF India Ltd rank in Chemicals & Petrochemicals?
Compare BASF India Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
BASF India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹3.5K Cr, net profit ₹64 Cr.
Full financials →📊 Revenue & Sales Performance
- →Agricultural Solutions business is expected to grow driven by volume recovery in upcoming rabbi season, new product launches, and focus on specialty crops like rice and rubber-based applications (2 and 3 wheelers).
- →Industrial Solutions segment is projected to grow with expansion in dispersion business, EV-related performance chemicals, and plastic additives despite pricing pressures.
- →Nutrition and Care segment shows positive momentum with volume and price increases, driven by personal care, skin care, and flavors & fragrances.
- →Performance Materials segment growth expected to be moderate due to ongoing pricing pressure and overcapacity in upstream chemicals, especially from China.
- →The company is investing in capacity upgrades (e.g., Cellesto asset upgrade) to increase local manufacturing and serve growing automotive sectors.
- →Pricing environment remains challenging overall; volume growth is a key focus area.
- →Continuous portfolio strengthening and innovation in core chemical businesses to drive mid to long-term growth.
📈 Profitability & Margins
- →Earnings/profits have been impacted recently by higher input costs and unfavorable product mix, leading to a 27% reduction in PBT before exceptional items for six months compared to last year.
- →Nutrition and Care segment shows promising growth with a 50% increase in profitability (profits nearly doubled), supported by volume and price increases.
- →Industrial Solutions segment has stable growth with margin improvements and is expected to earn more than the current 5% EBIT margin.
- →Agricultural Solutions business remains positive long-term due to global food demand and ongoing innovation, despite short-term volume challenges from weather.
- →Royalty income may fluctuate based on product mix but not necessarily tied to overall sales growth.
- →Strategic investments and capacity upgrades (e.g., Celesto) support future volume and sales growth, particularly in automotive rubber segments.
- →Management focuses on operational efficiencies, cost control, and portfolio mix improvements to enhance profitability.
- →No forward-looking financial guidance provided, but the outlook is cautiously optimistic with ongoing growth drivers.
🏗️ Capital Expenditure Plans
- →Upgradation of the Cellesto asset at the Hedge location underway, including capacity improvement and a large building to support future growth. (Page 13)
- →Investments aimed at modernizing lines, increasing automation, improving efficiency, and localizing imports (e.g., parts from Germany) to enhance profitability. (Page 14)
- →Ongoing evaluation of new project opportunities, both organic and inorganic, to strengthen core chemical businesses. (Page 14)
- →Continued Capex will be considered in India for attractive business cases despite global Capex expected to be below depreciation until 2028 due to large investments in China. (Page 11)
- →Investment focus on performance materials segment, engineering plastics, and other strategic areas to increase manufacturing product share in India aligned with growth in automotive and other sectors. (Pages 9, 13)
💰 Fundraising & Capital Structure
- →No specific forward-looking statements on fundraising through debt or equity in India are made at this time.
- →The company has consistently maintained a healthy and near debt-free position locally.
- →Globally, the parent company has an active strategy to reduce debt.
- →While options for improving the business and investing in India are continuously evaluated, there is no current plan for promoter stake sale or similar fundraising in India.
- →Capital expenditure (Capex) for investments will be considered only if there is a solid business case.
- →Overall, focus remains on strong financial health with no immediate plans for raising funds through debt or equity in India.
📋 Order Book & Pipeline
- →On page 12, Mr. Alexander Gerding mentioned a good pipeline of orders in the process catalyst part of the performance chemical segment.
- →However, some project delays have also delayed delivery and closure of these orders.
- →The paint industry, important for the dispersant business, had been flat or degrowing over the last 10 years but is now showing positive off-take, indicating potential order growth.
- →No specific quantitative values or exact current orderbook size were disclosed.
- →The company is actively evaluating new project opportunities, both organic and inorganic, to strengthen the core chemical business, which implies ongoing and future order prospects.
Key Metrics
Frequently Asked Questions
What were BASF India Ltd Q2 FY26 results?
Agricultural Solutions business is expected to grow driven by volume recovery in upcoming rabbi season, new product launches, and focus on specialty crops like rice and rubber-based applications (2 and 3 wheelers). Earnings/profits have been impacted recently by higher input costs and unfavorable product mix, leading to a 27% reduction in PBT before exceptional items for six months compared to last year.
What is BASF India Ltd share price analysis?
BASF India Ltd currently shows a neutral. The stock trades at a P/E of 28.2 with a market cap of ₹17,473 Cr. Investors should review the full earnings analysis for detailed insights.
Is BASF India Ltd planning capital expenditure?
Upgradation of the Cellesto asset at the Hedge location underway, including capacity improvement and a large building to support future growth.
Keep BASF India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.